Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Pneumonia Therapeutics Market In 2029?

The market size of pneumonia therapeutics has been expanding swiftly in the last few years. The market is predicted to rise from $10.35 billion in 2024 to $11.46 billion in 2025, maintaining a compound annual growth rate (CAGR) of 10.7%. The historical growth is due to factors such as emergence of drug-resistant strains, surge in cognizance about pneumonia prevention, increase in the elderly and those with compromised immune systems, broadened vaccination campaigns, and enhancement in healthcare infrastructure.

Predictions indicate significant expansion in the pneumonia therapeutics market in the upcoming years. The market is set to escalate to$17.11 billion by 2029″ with a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this growth include the rise in antibiotic-resistant strains, an increase in pneumonia cases amongst older populations, the use of telemedicine for prompt diagnosis, elevated spending on healthcare in developing markets, augmented funding in infectious disease research, and amplified awareness campaigns. The forecasted period will also witness trends such as the creation of monoclonal antibodies, the application of inhalable antibiotics, advancements in mRNA-based vaccines, use of AI for diagnostic purposes, implementation of host-targeted treatments, new immunomodulators, and progress in quick point-of-care diagnostic platforms.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21258&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pneumonia Therapeutics Market?

The escalation in pneumonia incidents is projected to propel the expansion of the pneumonia therapeutics market in the future. Pneumonia is a lung infection that inflames the air sacs, frequently resulting in symptoms such as coughing, fever, and difficulty breathing. The hike in pneumonia cases can be attributed to a variety of factors such as old age, air pollution, smoking, compromised immune systems, antimicrobial resistance, and the transmission of respiratory infections like COVID-19 or flu. Pneumonia therapeutics play a crucial role in fighting the root cause of the infection, which could be bacteria, viruses, or fungi, by utilising specific medications whilst assisting recovery through oxygen therapy, anti-inflammatory drugs, and symptom management. For example, as per the National Center for Biotechnology Information, a government agency based in the US, in January 2023, pneumonia impacts approximately 120 million individuals globally each year, causing around 1.3 million fatalities. Almost 80% of pediatric pneumonia deaths are seen in children under two in developing nations. Thus, the rising incidence of pneumonia is fueling the expansion of the pneumonia therapeutics market.

Which Key Market Segments Comprise the Pneumonia Therapeutics Market and Drive Its Revenue Growth?

The pneumonia therapeuticsmarket covered in this report is segmented –

1) By Product: Drugs; Vaccine; Oxygen Therapy

2) By Infection: Hospital-Acquired Pneumonia (HAP); Community-Acquired Pneumonia (CAP); Ventilator-Associated Pneumonia (VAP)

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration

4) By End Use: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Drugs: Antibiotics; Antiviral Drugs; Antifungal Drugs; Corticosteroids; Other Drugs

2) By Vaccine: Pneumococcal Vaccines; Haemophilus Influenzae Type B (Hib) Vaccines; Influenza Vaccines; Other Vaccines

3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC); Non-Invasive Ventilation (NIV); Mechanical Ventilation; Other Oxygen Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21258&type=smp

Which Areas Are Leading Regions in the Pneumonia Therapeutics Market Expansion Across the Globe?

North America was the largest region in the pneumonia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumonia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in thePneumonia Therapeutics Market Over the Coming Years?

Leading enterprises in the pneumonia therapy industry prioritize the formulation of innovative drug solutions and treatment procedures. These include antibiotic medications intended to tackle antibiotic resistance, thereby enhancing patient recovery rates. Essentially, an antibiotic drug is a specialized treatment for bacterial infections. For instance, Orchid Pharma Limited, a pharmaceutical firm based in India, joined forces with Cipla Limited, another Indian pharmaceutical company, to launch cefepime-enmetazobactam in June 2024. This antibiotic combination is typically employed in managing complex infections like UTIs and pneumonia, particularly the kinds resistant to other drugs. This aids in fighting bacterial resistance thereby ensuring productive therapy and reducing the reliance on more potent antibiotics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pneumonia-therapeutics-global-market-report

How Is the Pneumonia Therapeutics Market Conceptually Defined?

Pneumonia therapeutics refer to a range of treatments and medications used to manage and treat pneumonia, a lung infection that are caused by bacteria, viruses, or fungi. These therapeutics target the underlying pathogens, reduce inflammation, and improve respiratory functions. Treatments include antibiotics for bacterial pneumonia, antiviral medications for viral pneumonia, and antifungal agents for fungal infections.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21258

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model